Japan Agency for Medical Research and Development
E1039955
The Japan Agency for Medical Research and Development is a Japanese government-funded organization that coordinates and promotes medical research and innovation, from basic science through clinical application, to improve public health and foster the medical industry.
All labels observed (2)
| Label | Occurrences |
|---|---|
| Japan Agency for Medical Research and Development canonical | 1 |
| 日本医療研究開発機構 | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T13410455 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Japan Agency for Medical Research and Development Context triple: [National Research and Development Agency, hasExample, Japan Agency for Medical Research and Development]
-
A.
National Institutes of Natural Sciences of Japan
The National Institutes of Natural Sciences of Japan is a national research organization that oversees major scientific institutes and facilities in fields such as astronomy, physics, and biology.
-
B.
Pharmaceuticals and Medical Devices Agency Japan
The Pharmaceuticals and Medical Devices Agency (PMDA) is Japan’s regulatory authority responsible for the review, approval, and safety monitoring of pharmaceuticals and medical devices.
-
C.
Japanese Ministry of Health and Welfare
The Japanese Ministry of Health and Welfare was a former government ministry of Japan responsible for national public health policy, medical services, and social welfare programs before its functions were merged into the Ministry of Health, Labour and Welfare.
-
D.
Tohoku Medical Megabank Organization
Tohoku Medical Megabank Organization is a large-scale biomedical research institute at Tohoku University that builds extensive biobanks and genomic databases to advance personalized medicine and post-disaster health research in Japan.
-
E.
Kitasato Institute
The Kitasato Institute is a Japanese medical research and educational organization renowned for its pioneering work in infectious diseases, immunology, and public health.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Japan Agency for Medical Research and Development Target entity description: The Japan Agency for Medical Research and Development is a Japanese government-funded organization that coordinates and promotes medical research and innovation, from basic science through clinical application, to improve public health and foster the medical industry.
-
A.
National Institutes of Natural Sciences of Japan
The National Institutes of Natural Sciences of Japan is a national research organization that oversees major scientific institutes and facilities in fields such as astronomy, physics, and biology.
-
B.
Pharmaceuticals and Medical Devices Agency Japan
The Pharmaceuticals and Medical Devices Agency (PMDA) is Japan’s regulatory authority responsible for the review, approval, and safety monitoring of pharmaceuticals and medical devices.
-
C.
Japanese Ministry of Health and Welfare
The Japanese Ministry of Health and Welfare was a former government ministry of Japan responsible for national public health policy, medical services, and social welfare programs before its functions were merged into the Ministry of Health, Labour and Welfare.
-
D.
Tohoku Medical Megabank Organization
Tohoku Medical Megabank Organization is a large-scale biomedical research institute at Tohoku University that builds extensive biobanks and genomic databases to advance personalized medicine and post-disaster health research in Japan.
-
E.
Kitasato Institute
The Kitasato Institute is a Japanese medical research and educational organization renowned for its pioneering work in infectious diseases, immunology, and public health.
- F. None of above. chosen
Statements (48)
| Predicate | Object |
|---|---|
| instanceOf |
funding agency
ⓘ
government agency ⓘ medical research organization ⓘ |
| abbreviation | AMED ⓘ |
| coordinatesWith |
hospitals in Japan
ⓘ
international research organizations ⓘ medical device manufacturers ⓘ national research institutes in Japan ⓘ pharmaceutical companies ⓘ universities in Japan ⓘ |
| country | Japan ⓘ |
| fieldOfWork |
cancer research
ⓘ
clinical research ⓘ drug discovery ⓘ genomic medicine ⓘ infectious disease research ⓘ medical device development ⓘ medical research ⓘ neurodegenerative disease research ⓘ rare disease research ⓘ regenerative medicine ⓘ translational research ⓘ vaccine development ⓘ |
| fundedBy | Government of Japan ⓘ |
| goal |
to integrate medical R&D funding across Japanese ministries
ⓘ
to strengthen Japan’s global competitiveness in medical science ⓘ |
| headquartersLocation |
Chiyoda, Tokyo
ⓘ
Tokyo ⓘ |
| inception | 2015 ⓘ |
| jurisdiction | Japan ⓘ |
| languageOfWorkOrName |
English
ⓘ
Japanese ⓘ |
| legalForm | independent administrative agency ⓘ |
| mission |
to accelerate translation of basic research into clinical applications
ⓘ
to coordinate and promote medical research and development in Japan ⓘ to foster the medical and pharmaceutical industry ⓘ to improve public health through medical innovation ⓘ |
| nativeName | 日本医療研究開発機構 ⓘ |
| nativeNameLanguage | Japanese ⓘ |
| officialWebsite | https://www.amed.go.jp/ ⓘ |
| operatedBy | Government of Japan ⓘ |
| parentOrganization |
Cabinet Office of Japan
ⓘ
Ministry of Economy, Trade and Industry (Japan) ⓘ
linked to:
Ministry of Economy, Trade and Industry
Ministry of Education, Culture, Sports, Science and Technology (Japan) ⓘ
linked to:
Ministry of Education of Japan
Ministry of Health, Labour and Welfare (Japan) ⓘ |
| replaced |
Japan Agency for Medical Research and Development-related programs in multiple ministries
ⓘ
Japan Science and Technology Agency medical R&D functions ⓘ |
| shortName | AMED ⓘ |
How these facts were elicited
The pipeline generated the facts above by prompting gpt-5.1 with this entity's name + description and the instruction below.
Instruction
You are a knowledge base construction expert. Given a subject entity and a description of it, return factual statements that you know for the subject as a JSON list of dictionaries(triples), where keys must be "subject", "predicate" and "object". The number of facts may be very high, between 25 to 50 or more, for very popular subjects. For less popular subjects, the number of facts can be very low, like 5 or 10. # Requirements - If you don't know the subject at all, return an empty list. - If the subject is not a named entity, return an empty list. - Include at least one triple where predicate is "instanceOf". - Do not get too wordy. - Separate several objects into multiple triples with one object.
Input
Subject: Japan Agency for Medical Research and Development Description of subject: The Japan Agency for Medical Research and Development is a Japanese government-funded organization that coordinates and promotes medical research and innovation, from basic science through clinical application, to improve public health and foster the medical industry.
Referenced by (2)
Full triples — surface form annotated when it differs from this entity's canonical label.
National Research and Development Agency
→
hasExample
→
Japan Agency for Medical Research and Development
ⓘ
linked to: Japan Agency for Medical Research and Development